By sequentially silencing ERM and CD44 proteins in resistant breast cancer cells, we showed that CD44 and radixin, in particular, were required for P-gp-mediated drug efflux functionality, whereas all ERM proteins play a significant role in the vesicular transfer of functional P-gp to the recipient cells [81]. This evidence concerns the gene RDX and breast cancer.